The interaction between the carboxy terminus of transmembrane receptors with the conserved PDZ binding module of adaptor proteins has emerged as a major mechanism of organizing signal-transduction protein complexes. The syndecan family of transmembrane proteoglycans belongs to this large group of PDZ- binding cell surface receptors. Until recently, the generally held concept of proteoglycan functions was centered on their heparan sulfate chains as the active component involved in binding of growth factors and of extracellular matrix proteins. This view is undergoing a revision, however, as a consequence of newly emerging findings, which suggest that the highly conserved cytoplasmic tails of the syndecan family of transmembrane proteoglycans also participate in the transduction of outside-in signals. While all the syndecans possess a PDZ-binding carboxy- terminus, the widely expressed syndecan-4 contains a unique phosphatidylinositol 4,5-bisphosphate binding domain in its cytoplasmic tail, and facilitates the activation of protein kinase C alpha. Recent findings from our laboratory indicate that the interaction between the cytoplasmic tail of syndecan-4 and PDZ domain-containing protein(s) is essential for the cellular response to basic fibroblast growth factor, as demonstrated by the impairment of migration, of proliferation, and of vascular network formation by endothelial cells upon the disruption of this interaction. The objective of this proposal is to elucidate the nature of the signaling mechanism through the PDZ-syndecan-4 interaction, employing the recently identified syndecan-4 PDZ partner synectin as a prototype. This interaction is part of a novel FGF signaling pathway, and forms a new paradigm for the regulation of signal transduction. We will focus on (1) characterizing the binding mechanism between syndecan-4 and synectin, (2) identifying additional synectin binding partners other than syndecan-4, in order to determine further downstream members of the syndecan-4-mediated signaling pathway, and (3) characterize the functions of synectin in general, and the endothelial cell-specific ones in particular, by a synectin gene knockout mouse model.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL067960-01A1
Application #
6545320
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Goldman, Stephen
Project Start
2002-08-01
Project End
2006-07-31
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
1
Fiscal Year
2002
Total Cost
$265,770
Indirect Cost
Name
Dartmouth College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Horowitz, Arie; Simons, Michael (2009) Branching morphogenesis. Circ Res 104:e21
Garnaas, Maija K; Moodie, Karen L; Liu, Miao-liang et al. (2008) Syx, a RhoA guanine exchange factor, is essential for angiogenesis in Vivo. Circ Res 103:710-6
Horowitz, Arie; Simons, Michael (2008) Branching morphogenesis. Circ Res 103:784-95
Salikhova, Anna; Wang, Ling; Lanahan, Anthony A et al. (2008) Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res 103:e71-9
Chittenden, Thomas W; Claes, Filip; Lanahan, Anthony A et al. (2006) Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 10:783-95
Naccache, Samia N; Hasson, Tama; Horowitz, Arie (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles. Proc Natl Acad Sci U S A 103:12735-40